| 1 |
Ding D, Xu S, da Silva-Júnior EF, Liu X, Zhan P. Medicinal chemistry insights into antiviral peptidomimetics. Drug Discov Today 2023;28:103468. [PMID: 36528280 DOI: 10.1016/j.drudis.2022.103468] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Okamoto H, Murano SA, Ikekawa K, Katsuyama M, Konno S, Taguchi A, Takayama K, Taniguchi A, Hayashi Y. Inactivation of myostatin by photooxygenation using functionalized d-peptides. RSC Med Chem 2023;14:386-92. [PMID: 36846372 DOI: 10.1039/d2md00425a] [Reference Citation Analysis]
|
| 3 |
Kulhankova K, Traore S, Cheng X, Benk-Fortin H, Hallée S, Harvey M, Roberge J, Couture F, Gross T, Newby G, Liu D, Tarantal A, Guay D, McCray P. Shuttle Peptide Delivers Base Editor RNPs to Rhesus Monkey Airway Epithelial Cells In Vivo. Res Sq 2023:rs. [PMID: 36824928 DOI: 10.21203/rs.3.rs-2540755/v1] [Reference Citation Analysis]
|
| 4 |
Ma S, Yang K, Li Z, Li L, Feng Y, Wang X, Wang J, Zhu Z, Wang Z, Wang J, Zhu Y, Liu L. A retro-inverso modified peptide alleviated ovalbumin-induced asthma model by affecting glycerophospholipid and purine metabolism of immune cells. Pulm Pharmacol Ther 2023;78:102185. [PMID: 36563740 DOI: 10.1016/j.pupt.2022.102185] [Reference Citation Analysis]
|
| 5 |
Zheng M, Wu X, Lu C, Zhang W, Tang S, Luo Y, Liu D. Polypept(o)ide-based bactericides: weapons against antibiotic-resistant bacterial infections. Materials Today Chemistry 2023;27:101270. [DOI: 10.1016/j.mtchem.2022.101270] [Reference Citation Analysis]
|
| 6 |
Zamuner A, Pasquato A, Castagliuolo I, Dettin M, Brun P. Selective Grafting of Protease-Resistant Adhesive Peptides on Titanium Surfaces. Molecules 2022;27. [PMID: 36557865 DOI: 10.3390/molecules27248727] [Reference Citation Analysis]
|
| 7 |
Carrera-aubesart A, Defaus S, Pérez-peinado C, Sandín D, Torrent M, Jiménez MÁ, Andreu D. Examining Topoisomers of a Snake-Venom-Derived Peptide for Improved Antimicrobial and Antitumoral Properties. Biomedicines 2022;10:2110. [DOI: 10.3390/biomedicines10092110] [Reference Citation Analysis]
|
| 8 |
Golosov AA, Flyer AN, Monovich LG. Design and Discovery of Orally Bioavailable Macrocycles: Toward Orally Bioavailable Peptide Therapeutics. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch008] [Reference Citation Analysis]
|
| 9 |
Doty AC, Jarvis CM, Munsell EV. Formulation Strategies to Enable Delivery of Therapeutic Peptides across Cell Membranes. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch009] [Reference Citation Analysis]
|
| 10 |
. Editors’ Biographies. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ot001] [Reference Citation Analysis]
|
| 11 |
Sawyer TK, Biswas K. Peptide Drug Discovery Raison d’Etre: Engineering Mindset, Design Rules and Screening Tools. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch001] [Reference Citation Analysis]
|
| 12 |
Adaligil E, Fairbrother WJ. NMR Spectroscopy for Studying Peptide Conformations and Cell Permeability. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch006] [Reference Citation Analysis]
|
| 13 |
Pei D. Designing Cell-Permeable Peptide Therapeutics That Enter the Cell by Endocytosis. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch007] [Reference Citation Analysis]
|
| 14 |
. Subject Index. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ix002] [Reference Citation Analysis]
|
| 15 |
. Title, Copyright, Foreword. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.fw001] [Reference Citation Analysis]
|
| 16 |
Mulligan VK, Hosseinzadeh P. Computational Design of Peptide-Based Binders to Therapeutic Targets. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch003] [Reference Citation Analysis]
|
| 17 |
Ghodge SV, Biswas K, Golosov AA. Preface. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.pr001] [Reference Citation Analysis]
|
| 18 |
Helmling C, Cunningham CN. mRNA Display and Its Growing Potential in the Discovery of De Novo Therapeutic Peptide Candidates. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch002] [Reference Citation Analysis]
|
| 19 |
Kamenik AS, Linker SM, Riniker S. Matching Simulations and Experiments of Conformationally Flexible Cyclic Peptides: Steps toward a Holistic View of Passive Membrane Permeability. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch005] [Reference Citation Analysis]
|
| 20 |
. Approaching the Next Inflection in Peptide Therapeutics: Attaining Cell Permeability and Oral Bioavailability. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417] [Reference Citation Analysis]
|
| 21 |
Duggal R, Hochman J. Optimization of Peptide Drug Exposures for Pharmacological Efficacy: DMPK Considerations. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch010] [Reference Citation Analysis]
|
| 22 |
Sindhikara D, Johnston J. Roles of Conformations on Predictions of Peptide Properties. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch004] [Reference Citation Analysis]
|
| 23 |
Jiao L, Dong Q, Zhai W, Zhao W, Shi P, Wu Y, Zhou X, Gao Y. A PD-L1 and VEGFR2 dual targeted peptide and its combination with irradiation for cancer immunotherapy. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106343] [Reference Citation Analysis]
|
| 24 |
Takayama K, Hitachi K, Okamoto H, Saitoh M, Odagiri M, Ohfusa R, Shimada T, Taguchi A, Taniguchi A, Tsuchida K, Hayashi Y. Development of Myostatin Inhibitory d-Peptides to Enhance the Potency, Increasing Skeletal Muscle Mass in Mice. ACS Med Chem Lett 2022;13:492-8. [PMID: 35300091 DOI: 10.1021/acsmedchemlett.1c00705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 25 |
Gallo M, Defaus S, Andreu D. Disrupting GPCR Complexes with Smart Drug-like Peptides. Pharmaceutics 2022;14:161. [PMID: 35057055 DOI: 10.3390/pharmaceutics14010161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 26 |
Preston GW. Different directions for retro-inverso peptides. J Pept Sci 2021;:e3384. [PMID: 34889485 DOI: 10.1002/psc.3384] [Reference Citation Analysis]
|
| 27 |
Krishnan M, Choi J, Jang A, Yoon YK, Kim Y. Antiseptic 9-Meric Peptide with Potency against Carbapenem-Resistant Acinetobacter baumannii Infection. Int J Mol Sci 2021;22:12520. [PMID: 34830401 DOI: 10.3390/ijms222212520] [Reference Citation Analysis]
|
